Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu

Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.


Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Publications & Presentations

1 2 3 4 > >>
    1. Dickson M C, Nguyen M M, Patel C, Graich S, Benson C, Cothran T, Skrepnek G H. Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation. Advances in Therapy. 2023; 40 : 349-66

    2. Boylan P, Skrepnek G, Neely S. Medication therapy problems assessment within medication history objective structured clinical examinations using standardized patients versus peer actors. Journal of the American College of Clinical Pharmacy. 2023; 6 : 354-362

    3. Nguyen M M, Dickson M C, Skrepnek G H. Medicaid Value-Based Contract (VBC) in autoimmune diseases involving tumor necrosis factor. Oklahoma Health Care Authority. 2022

    4. Nguyen M, Dickson M C, Skrepnek G H. Medicaid Value-Based Contract (VBC) in partial-onset seizure disorder. Oklahoma Health Care Authority. 2022

    5. Dickson M C, Nguyen M M, Skrepnek G H. Medicaid Value-Based Contract (VBC) in the prevention of migraine. Oklahoma Health Care Authority. 2022

1 2 3 4 > >>



Grants

1 2 3 >>
    1. HIV Adherence Services. Start Date: 2022. End Date: 2023.

    2. Patterns of Care, Outcomes, and Barriers to Treatment Success or Vaccination Associated with Adult Community-Acquired Pneumonia in Medicaid. Misc Non-Federal. Start Date: 2021. End Date: 2022.

    3. [Service Agreement] Opioid Use Under Oklahoma Senate Bill 848.. Non-federal. Start Date: 2020. End Date: 2020.

    4. C1097002 - Improving evidence-based antibiotic use for treatment of infections commonly seen in long term . Federal Non-NIH. Start Date: 2019. End Date: 2020.

    5. C2010628 - Drug Utilization Review 2020 [Service Award]. State Agency. Start Date: 2019. End Date: 2020.

1 2 3 >>



Awards and Honors


no results

Education


no results